7754 Stock Overview
Develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
AnnJi Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$34.80 |
| 52 Week High | NT$72.40 |
| 52 Week Low | NT$29.00 |
| Beta | 0 |
| 1 Month Change | 7.74% |
| 3 Month Change | -1.00% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7754 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 15.6% | 1.1% | 0.4% |
| 1Y | n/a | -0.3% | 27.0% |
Return vs Industry: Insufficient data to determine how 7754 performed against the TW Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 7754 performed against the TW Market.
Price Volatility
| 7754 volatility | |
|---|---|
| 7754 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 3.4% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 7754 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 7754's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Wendy Huang | www.ajpharm.com |
AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy, a neurodegenerative disease; AJ202 for androgenetic alopecia; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. AnnJi Pharmaceutical Co., Ltd.
AnnJi Pharmaceutical Co., Ltd. Fundamentals Summary
| 7754 fundamental statistics | |
|---|---|
| Market cap | NT$3.28b |
| Earnings (TTM) | -NT$365.04m |
| Revenue (TTM) | NT$182.04m |
17.9x
P/S Ratio-8.9x
P/E RatioIs 7754 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7754 income statement (TTM) | |
|---|---|
| Revenue | NT$182.04m |
| Cost of Revenue | NT$160.56m |
| Gross Profit | NT$21.47m |
| Other Expenses | NT$386.52m |
| Earnings | -NT$365.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.90 |
| Gross Margin | 11.80% |
| Net Profit Margin | -200.53% |
| Debt/Equity Ratio | 0% |
How did 7754 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 16:02 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AnnJi Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|